BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31189228)

  • 41. Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths.
    Li Q; Larivée P; Courteau J; Couillard S; Poder TG; Carrier N; Bélanger M; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():331-341. PubMed ID: 30787603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes.
    Aksoy E; Karakurt Z; Gungor S; Ocakli B; Ozmen İ; Yildirim E; Tuncay E; Agca MC; Ciftaslan Goksenoglu N; Adigüzel N
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2721-2730. PubMed ID: 30233162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The association between blood eosinophils and clinical outcome of acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Liu H; Xie Y; Huang Y; Luo K; Gu Y; Zhang H; Xu Y; Chen X
    Respir Med; 2024 Feb; 222():107501. PubMed ID: 38104787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
    Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
    Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicentre double-blind randomised controlled trial of systematic corticosteroid therapy in patients with acute exacerbations of chronic obstructive pulmonary disease admitted to hospital with higher eosinophil levels: the ECHO protocol.
    Liang L; Lin Y; Feng L; Shao S; Cao S; Rong H; Chu S; Xie W; Cai S; Wang J; Tong Z
    BMJ Open; 2023 May; 13(5):e066354. PubMed ID: 37247957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of CRP, Procalcitonin, Neutrophil Counts, Eosinophil Counts, sTREM-1, and OPN between Pneumonic and Nonpneumonic Exacerbations in COPD Patients.
    Mou S; Zhang W; Deng Y; Tang Z; Jiang D
    Can Respir J; 2022; 2022():7609083. PubMed ID: 35400078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated Peripheral Blood Eosinophils during Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and clinical significance.
    Al Sibani M; Al Alawi A; Al Aghbari J
    Sultan Qaboos Univ Med J; 2022 Aug; 22(3):339-342. PubMed ID: 36072062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The expression and the clinical significance of eosinophils, PCT and CRP in patients with acute exacerbation of chronic obstructive pulmonary disease complicated with pulmonary infection.
    Zhou W; Tan J
    Am J Transl Res; 2021; 13(4):3451-3458. PubMed ID: 34017521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
    Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
    COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Differences between Eosinophilic and Noneosinophilic Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study.
    Dai G; Ran Y; Wang J; Chen X; Peng J; Li X; Deng H; Xiao M; Zhu T
    Mediators Inflamm; 2020; 2020():1059079. PubMed ID: 33273887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
    Kiani A; Rahimi F; Afaghi S; Paat M; Varharam M; Dizaji MK; Dastoorpoor M; Abedini A
    Can Respir J; 2023; 2023():8678702. PubMed ID: 37153722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD.
    Hasegawa K; Camargo CA
    Respirology; 2016 May; 21(4):761-4. PubMed ID: 26699685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
    Moretti M; Fagnani S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
    Yao C; Liu X; Tang Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations.
    Ko FWS; Chan KP; Ngai J; Ng SS; Yip WH; Ip A; Chan TO; Hui DSC
    Respirology; 2020 Mar; 25(3):259-266. PubMed ID: 31385389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis.
    Greulich T; Tüffers J; Mager S; Eder A; Maxheim M; Alter P; Schmeck B; Vogelmeier CF
    Respir Res; 2020 May; 21(1):106. PubMed ID: 32375777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
    Bafadhel M; McKenna S; Terry S; Mistry V; Pancholi M; Venge P; Lomas DA; Barer MR; Johnston SL; Pavord ID; Brightling CE
    Am J Respir Crit Care Med; 2012 Jul; 186(1):48-55. PubMed ID: 22447964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stability in eosinophil categorisation during subsequent severe exacerbations of COPD.
    Citgez E; van der Palen J; van der Valk P; Kerstjens HAM; Brusse-Keizer M
    BMJ Open Respir Res; 2021 Aug; 8(1):. PubMed ID: 34376399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COPD exacerbation phenotypes in a real-world five year hospitalisation cohort.
    Jones TPW; Brown J; Hurst JR; Vancheeswaran R; Brill S
    Respir Med; 2020 Jun; 167():105979. PubMed ID: 32421545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.